1. Home
  2. ANIX vs KUKE Comparison

ANIX vs KUKE Comparison

Compare ANIX & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIX
  • KUKE
  • Stock Information
  • Founded
  • ANIX 1982
  • KUKE 2002
  • Country
  • ANIX United States
  • KUKE China
  • Employees
  • ANIX N/A
  • KUKE N/A
  • Industry
  • ANIX Biotechnology: Pharmaceutical Preparations
  • KUKE Other Consumer Services
  • Sector
  • ANIX Health Care
  • KUKE Real Estate
  • Exchange
  • ANIX Nasdaq
  • KUKE Nasdaq
  • Market Cap
  • ANIX 95.7M
  • KUKE 86.8M
  • IPO Year
  • ANIX 1987
  • KUKE 2021
  • Fundamental
  • Price
  • ANIX $3.35
  • KUKE $1.59
  • Analyst Decision
  • ANIX Strong Buy
  • KUKE
  • Analyst Count
  • ANIX 3
  • KUKE 0
  • Target Price
  • ANIX $9.00
  • KUKE N/A
  • AVG Volume (30 Days)
  • ANIX 108.8K
  • KUKE 33.7K
  • Earning Date
  • ANIX 09-10-2025
  • KUKE 10-15-2025
  • Dividend Yield
  • ANIX N/A
  • KUKE N/A
  • EPS Growth
  • ANIX N/A
  • KUKE N/A
  • EPS
  • ANIX N/A
  • KUKE N/A
  • Revenue
  • ANIX N/A
  • KUKE $9,442,397.00
  • Revenue This Year
  • ANIX N/A
  • KUKE N/A
  • Revenue Next Year
  • ANIX N/A
  • KUKE N/A
  • P/E Ratio
  • ANIX N/A
  • KUKE N/A
  • Revenue Growth
  • ANIX N/A
  • KUKE N/A
  • 52 Week Low
  • ANIX $2.07
  • KUKE $1.45
  • 52 Week High
  • ANIX $4.20
  • KUKE $10.00
  • Technical
  • Relative Strength Index (RSI)
  • ANIX 59.63
  • KUKE 39.09
  • Support Level
  • ANIX $2.93
  • KUKE $1.56
  • Resistance Level
  • ANIX $3.09
  • KUKE $1.68
  • Average True Range (ATR)
  • ANIX 0.16
  • KUKE 0.16
  • MACD
  • ANIX 0.06
  • KUKE 0.02
  • Stochastic Oscillator
  • ANIX 62.69
  • KUKE 16.82

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

About KUKE Kuke Music Holding Limited

Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.

Share on Social Networks: